A controversial pilot project reduced the cost of the most effective malaria drugs by giving manufacturers, such as Guilin Pharmaceutical in China, subsidies.
Frederic J. Brown/AFP/Getty Images
November 16, 2012 After months of debate, the Global Fund announced plans to wind down a controversial pilot project that subsidizes malaria drugs in Africa. Some health workers in the U.S. fault the decision, saying it doesn't address the major challenges of treating malaria in poor countries.
NPR thanks our sponsors
Become an NPR sponsor